Trupti D. Vardam

1.3k total citations
10 papers, 546 citations indexed

About

Trupti D. Vardam is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Trupti D. Vardam has authored 10 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Trupti D. Vardam's work include Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (3 papers) and Immune Response and Inflammation (2 papers). Trupti D. Vardam is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (3 papers) and Immune Response and Inflammation (2 papers). Trupti D. Vardam collaborates with scholars based in United States and Germany. Trupti D. Vardam's co-authors include Sharon S. Evans, Michelle M. Appenheimer, Heinz Baumann, Lei Zhou, Jason B. Muhitch, Rakesh K. Jain, Daniel T. Fisher, Sandra O. Gollnick, Dan G. Duda and Joseph J. Skitzki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and JNCI Journal of the National Cancer Institute.

In The Last Decade

Trupti D. Vardam

10 papers receiving 536 citations

Peers

Trupti D. Vardam
Raffi Manoukian United States
Adel Ersek United Kingdom
Ralph Rossi Australia
Trupti D. Vardam
Citations per year, relative to Trupti D. Vardam Trupti D. Vardam (= 1×) peers Justyna Czapla

Countries citing papers authored by Trupti D. Vardam

Since Specialization
Citations

This map shows the geographic impact of Trupti D. Vardam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Trupti D. Vardam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Trupti D. Vardam more than expected).

Fields of papers citing papers by Trupti D. Vardam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Trupti D. Vardam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Trupti D. Vardam. The network helps show where Trupti D. Vardam may publish in the future.

Co-authorship network of co-authors of Trupti D. Vardam

This figure shows the co-authorship network connecting the top 25 collaborators of Trupti D. Vardam. A scholar is included among the top collaborators of Trupti D. Vardam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Trupti D. Vardam. Trupti D. Vardam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Ito, Fumito, Trupti D. Vardam, Michelle M. Appenheimer, et al.. (2019). In situ thermal ablation augments antitumor efficacy of adoptive T cell therapy. International Journal of Hyperthermia. 36(sup1). 22–36. 22 indexed citations
2.
Lee, Eudocia Q., Dan G. Duda, Alona Muzikansky, et al.. (2018). Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade Glioma. Clinical Cancer Research. 24(19). 4643–4649. 49 indexed citations
3.
Vardam, Trupti D. & Niroshana Anandasabapathy. (2017). Langerhans Cells Orchestrate TFH-Dependent Humoral Immunity. Journal of Investigative Dermatology. 137(9). 1826–1828. 7 indexed citations
4.
Batista, Ana, Lars Riedemann, Trupti D. Vardam, & Rakesh K. Jain. (2015). Targeting the Tumor Microenvironment to Enhance Pediatric Brain Cancer Treatment. The Cancer Journal. 21(4). 307–313. 14 indexed citations
5.
Askoxylakis, Vasileios, Gino B. Ferraro, David P. Kodack, et al.. (2015). Preclinical Efficacy of Ado-trastuzumab Emtansine in the Brain Microenvironment. JNCI Journal of the National Cancer Institute. 108(2). 57 indexed citations
6.
Han, Shiwei, Jelena Grahovac, Trupti D. Vardam, & Yves Boucher. (2015). Abstract B70: Combination of AT1R blockade with CD40 activation provides enhanced therapeutic efficacy for mouse pancreatic adenocarcinoma. Cancer Immunology Research. 3(10_Supplement). B70–B70. 1 indexed citations
7.
Samuel, Rekha, Laurence Dahéron, Shan Liao, et al.. (2013). Generation of functionally competent and durable engineered blood vessels from human induced pluripotent stem cells. Proceedings of the National Academy of Sciences. 110(31). 12774–12779. 121 indexed citations
8.
Fisher, Daniel T., Qing Chen, Joseph J. Skitzki, et al.. (2011). IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells. Journal of Clinical Investigation. 121(10). 3846–3859. 201 indexed citations
9.
Fisher, Daniel T., Trupti D. Vardam, Jason B. Muhitch, & Sharon S. Evans. (2009). Fine-tuning immune surveillance by fever-range thermal stress. Immunologic Research. 46(1-3). 177–188. 17 indexed citations
10.
Vardam, Trupti D., Lei Zhou, Michelle M. Appenheimer, et al.. (2007). Regulation of a lymphocyte–endothelial–IL-6 trans-signaling axis by fever-range thermal stress: Hot spot of immune surveillance. Cytokine. 39(1). 84–96. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026